What's New
MORE-
2025.05.31
InformationWe have launched our website
Our Mission & Vision
Every cancer is different. Its character also changes by treatments and progressions.
In order to provide the most appropriate treatment continuously, it is important to obtain information from cancer cells whenever necessary.
Althought it is not easy to extract cancer cells from a patient's body,
Cytona makes it possible to capture CTCs, the rare cells circulating in the patient's blood and is determined to develop technology that can collect cancer cells with minimal burden in treatments whenever necessary.
Cytona aims to contribute to conqueing cancer by broadly developing the technologies necessary for the clinical application of CTCs.
Development and sales of CTC capture devices and kits
R&D, manufacturing and sales of polymer CTC chips
Consulting services for CTC research
Research & Technology
Cytona's proprietary technology on polymer and micromolding has made it possible to manufacture a variety of microfluidic devices* from resin. Having a chemical structure that binds with biomolecules, this material can fix such molecules as antibodies, enzymes, and nucleic acids on its surface. The Polymer CTC Chip was developed using this technology and can selectively and efficiently capture cancer cells in the blood. Clinical research using patient blood has confirmed that CTCs can be captured with high sensitivity in various cancers, including lung cancer, malignant mesothelioma, colorectal cancer, prostate cancer, and breast cancer, and has published papers confirming this.
*Microfluidic device: A small chip-shaped device consisting of minute flow channels and liquid reservoirs, capable of feeding minute amounts of liquid to perform mixing, reactions, separation, and other operations.Cytona's Strength
- Proprietary polymer material technology and plastic micromolding technology
- The ability from development of microfluidic devices of resin to evaluation using biomolecules and cells
- Extensive track record in clinical research with university hospitals using cancer specimens
Product & Service
Cytona offers the Polymer CTC Chip, the key device, and the equipment to perform CTC capture tests with the chip. The equipment comes in two types, the manual type for simple processing and automated type for the processing of a large number of samples with reduced labor. Either way, Cytona provides full support to researchers and medical institutions in starting CTC research from scratch and putting the results into clinical use.
Polymer CTC Chip
By immobilizing the antibody of the user's choice, the chip captures CTCs expressing the corresponding antigen (capture target).
CTC Capture Kit
By manually supplying samples and operating the pump, blood samples or washing solutions can be run through the chip to perform CTC capture tests. This simple, low-cost system is ideal for starting CTC research.
Automated CTC Capture Device
Blood samples, cell processing fluids and washing fluids placed on a rack are automatically supplied to the chip, and liquids can be automatically delivered under preset conditions. In addition to CTC capture, the process can be automated up to the point of staining the marker to be examined by setting fluorescently labeled antibody solution.
We are happy to assist you in product purchases, researches, and clinical application from scratch.
Feel free to contact us.